Receptor Tyrosine Kinase Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
EXEL | A | Exelixis, Inc. | 2.77 | |
KALA | B | Kala Pharmaceuticals, Inc. | -0.71 | |
BPMC | C | Blueprint Medicines Corporation | 3.65 |
Related Industries: Biotechnology
Related ETFs - A few ETFs which own one or more of the above listed Receptor Tyrosine Kinase stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
IDNA | C | iShares Genomics Immunology and Healthcare ETF | 6.49 | |
PBE | C | PowerShares Dynamic Biotech & Genome | 5.8 | |
CANC | C | Tema Oncology ETF | 5.47 | |
FBT | A | First Trust Amex Biotech Index Fund | 3.66 | |
LABD | D | Direxion Daily S&P Biotech Bear 3X Shares | 3.52 |
Compare ETFs
- Receptor Tyrosine Kinase
Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. Of the 90 unique tyrosine kinase genes identified in the human genome, 58 encode receptor tyrosine kinase proteins.
Receptor tyrosine kinases have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Mutations in receptor tyrosine kinases lead to activation of a series of signalling cascades which have numerous effects on protein expression. Receptor tyrosine kinases are part of the larger family of protein tyrosine kinases, encompassing the receptor tyrosine kinase proteins which contain a transmembrane domain, as well as the non-receptor tyrosine kinases which do not possess transmembrane domains.
Popular Now
Recent Comments
- Cos3 on Adding float as advanced filter criteria?
- FriendlyOyster657 on BOOT
- TraderMike on Filtering by News?
- Dr_Duru on Filtering by News?
- TraderMike on Filtering by News?
From the Blog
Featured Articles